AxoGen (NASDAQ: AXGN)
AxoGen Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AxoGen Company Info
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
News & Analysis
Here's Why AxoGen Slipped Again Today
Investors wondering if they'll ever see a profit didn't get the outlook they wanted.
Here's Why AxoGen, Inc. Was Hammered Today
A scathing short-seller report started circulating at a bad time for the nerve repair specialist.
Here's Why AxoGen, Inc. Fell as Much as 18.6% Today
The healthcare company reported second-quarter 2018 earnings.
2 Biotech Stocks that Turned $8,000 into over $250,000
An $8,000 investment in these biotech stocks 10 years ago would be worth over $250,000 today. Are more gains ahead?
Valuation
Earnings Transcripts
AxoGen, inc (AXGN) Q3 2021 Earnings Call Transcript
AXGN earnings call for the period ending September 30, 2021.
AxoGen, inc (AXGN) Q2 2021 Earnings Call Transcript
AXGN earnings call for the period ending June 30, 2021.
AxoGen Inc (AXGN) Q1 2021 Earnings Call Transcript
AXGN earnings call for the period ending March 31, 2021.
AxoGen Inc (AXGN) Q3 2020 Earnings Call Transcript
AXGN earnings call for the period ending September 30, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.